Compare LXFR & CGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LXFR | CGC |
|---|---|---|
| Founded | 1898 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Pharmaceuticals and Biotechnology |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 460.7M | 401.0M |
| IPO Year | 2002 | 2023 |
| Metric | LXFR | CGC |
|---|---|---|
| Price | $17.11 | $0.97 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 145.0K | ★ 5.1M |
| Earning Date | 04-28-2026 | 05-29-2026 |
| Dividend Yield | ★ 3.65% | N/A |
| EPS Growth | N/A | ★ 84.17 |
| EPS | ★ 0.13 | N/A |
| Revenue | ★ $384,600,000.00 | $12,759,000.00 |
| Revenue This Year | N/A | $8.27 |
| Revenue Next Year | $5.01 | $15.68 |
| P/E Ratio | $131.23 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $11.19 | $0.84 |
| 52 Week High | $19.45 | $2.38 |
| Indicator | LXFR | CGC |
|---|---|---|
| Relative Strength Index (RSI) | 46.14 | 46.24 |
| Support Level | $16.68 | $0.93 |
| Resistance Level | $19.45 | $1.08 |
| Average True Range (ATR) | 0.63 | 0.04 |
| MACD | -0.24 | 0.01 |
| Stochastic Oscillator | 23.86 | 35.84 |
Luxfer Holdings PLC is engaged in materials engineering and the manufacture of materials, components, and gas containment products. The company has two reportable segments: Elektron and Gas Cylinders. The Elektron segment produces specialty materials based on magnesium and zirconium for applications in aerospace, defense, automotive, and industrial markets. The Gas Cylinders segment manufactures high-pressure gas containment products using aluminum alloys and carbon composite technologies for use in healthcare, emergency response, aerospace, and alternative fuel transportation markets.
Canopy Growth Corp is a cannabis company that produces, distributes, and sells a diverse range of cannabis and cannabis-related products for adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company supplies cannabis products in Canada, Europe, and Australia. It is focused on the medical and adult-use cannabis markets in Canada, offering a broad portfolio of brands and formats for medical cannabis patients and adult-use consumers. The Company operates through two reportable segments: Cannabis, which generates maximum revenue and includes the production, distribution, and sale of cannabis and cannabis-related products, and Storz & Bickel, which includes the production, distribution, and sale of vaporizers and accessories.